Tongxinluo Improves Apolipoprotein E-Deficient Mouse Heart Function.

Area of Science:

• Cardiovascular Research
• Pharmacology
• Traditional Chinese Medicine

Background:

• Previous studies indicated Tongxinluo (TXL) protects against myocardial ischemia-reperfusion injury and improves endothelial function.
• Hypercholesterolemia impairs heart function by affecting artery endothelial function and reducing microvascular density (MVD).

Purpose of the Study:

• To investigate if TXL improves hypercholesterolemia-impaired heart function in mice.
• To determine if TXL protects artery endothelial function and increases cardiac MVD.
• To explore the molecular mechanisms underlying TXL's cardiovascular protective effects.

Main Methods:

• Administration of TXL to ApoE-/- mice and wild-type controls.
• Assessment of serum lipid profiles, cardiac function (echocardiography), and aortic blood flow parameters.
• Evaluation of endothelium-dependent vasodilation and measurement of vascular endothelial growth factor (VEGF) and myocardial CD34 expression.

Main Results:

• TXL reduced triglyceride and VLDL levels but did not significantly alter total cholesterol.
• TXL improved cardiac function, enhanced aortic blood flow, and improved endothelium-dependent vasodilation in ApoE-/- mice.
• TXL treatment increased cardiac MVD and VEGF expression in ApoE-/- mice.

Conclusions:

• TXL improves cardiac function in ApoE-/- mice through multiple pathways, including lipid reduction and enhanced vascular function.
• TXL increases aortic blood supply capacity, vessel elasticity, and endothelium-dependent vasodilation.
• TXL enhances cardiac MVD, potentially via increased VEGF expression, contributing to its cardioprotective effects.